One growth hormone molecule binds asymmetrically to two subunits of a dimeric GHR. A recent study, reported in 2005, suggested that inactive GHR dimers are already present on the cell surface ...

Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.

Promising new approach developed for overcoming treatment resistance in oestrogen receptor-positive (ER+) breast cancer ...

Research has given us more molecular insights on how ... expression of both receptors can drive tumor growth through complex signaling network. Hormone receptor status including the presence ...

Bayer today showcased significant advancements in its pharmaceutical growth strategy and pipeline at its recent annual Pharma ...

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

Researchers studying over 2,000 Ashkenazi Jewish centenarians uncovered two rare IGF-1 gene variants linked to exceptional ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

"2025 is set to be a landmark year for Bayer Pharmaceuticals. We are bringing a number of groundbreaking products and our ...

Olema Pharmaceuticals palazestrant shows promise in late-stage trials for metastatic breast cancer with potential FDA ...

Unveiling how our bodies know what to eat Sponsored by Pennington Biomedical Research Center We know eating a balanced diet ...